Good afternoon and welcome to Markets Desk, your midday read on the stories moving money right now.
Oil is the headline macro trade today after the United States launched fresh strikes against Iran in response to attacks on commercial vessels in the Strait of Hormuz. Crude jumped sharply on the news, as traders priced in supply disruption risk through one of the world's most critical shipping corridors. A fragile regional truce now looks increasingly unstable, and energy markets are watching every headline.
Turning to pharma, Vertex Pharmaceuticals has agreed to acquire Crinetics for eighty-five dollars per share in cash, valuing the deal at roughly ten billion dollars in equity. Crinetics specializes in endocrine disorders, and the acquisition signals Vertex pushing aggressively beyond its cystic fibrosis franchise into new therapeutic territory. It is a significant bet on pipeline diversification.
And in tech, Meta Platforms finished June down eleven percent as investors grew increasingly skeptical of the company's artificial intelligence spending trajectory. The concern is not whether AI works — it is whether the returns justify the capital outlay at this scale and this pace. Meta has been among the heaviest spenders in the space, and the market is now demanding a clearer path to monetization.
That's the tape. Markets Desk, signing off the floor.
